+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Home Infusion Therapy Market Size, Share & Trends Analysis Report by Product (Infusion Pumps, Intravenous Sets), by Application (Anti-Infective, Endocrinology), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4031925
  • Report
  • February 2020
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • MORE
The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, according to this report registering a CAGR of 7.3% over the forecast period. Increasing incidences of hospital-acquired infections are some of the major factors contributing to the market growth. Home infusion therapy is considered an alternative to an extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster when compared to the hospital and are more comfortable at home.

Several government and non-government programs are carried out in order to spread awareness among people regarding home infusion therapy. In October 2019, the Centers for Medicare & Medicaid Services issued a rule stating that all home infusion therapy payments will get covered under the Bipartisan Budget Act of 2018. In addition, favorable government policies and regulations are expected to propel the market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law which states that all temporary payments of home infusion therapy in U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

Technological developments in home infusion therapy devices are also anticipated to make therapy more convenient and user-friendly for patients. For instance, in April 2017, B. Braun launched Easypump home infusion therapy app for both patients and the physician. This app will help patients to safely administer the medicine as per the requirements.

Further key findings from the report suggest:
  • Infusion pumps emerged as the largest product segment in 2019 owing to increasing use of delivery fluids such as nutrients and medications
  • The needleless connectors segment is projected to register the highest CAGR over the forecast period as they offer advantages such as improved safety
  • The anti-infective segment dominated the home infusion therapy market in 2019, as a large number of procedures are performed during the administration of medication such as antibiotics and antifungals
  • North America dominated the global market in 2019. With the increasing demand for new technologies, along with advanced healthcare infrastructure, North America is expected to continue to dominate the market through the forecast period
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region
  • Key market players include B. Braun Melsungen AG, Baxter, Caesarea Medical Electronics, CareFusion Corporation, Fresenius Kabi, ICU Medical, Inc., JMS Co. Ltd., Smiths Medical, Inc., and Terumo Corporation.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Home Infusion Therapy Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Application
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing geriatric population
3.4.1.2. Rising prevalence of chronic diseases
3.4.1.3. Recent technological advancements in infusion pumps
3.4.1.4. Home healthcare as cost effective alternative
3.4.1.5. Improving healthcare infrastructure in emerging economies
3.4.2. Market Restraint Analysis
3.4.2.1. Product recall
3.4.2.2. Presence of complicated reimbursement framework and reimbursement cuts
3.4.3. Industry Challenges
3.4.3.1. Rising cost of home infusion therapy
3.5. Home Infusion Therapy: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Home Infusion Therapy Market: Segment Analysis, by Product, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Home Infusion Therapy Market , by Product, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Infusion pumps
4.5.1.1. Ambulatory infusion pumps
4.5.2.1 Insulin pumps
4.5.2.2 Syringe pumps
4.5.2.3 Elastomeric pumps
4.5.2.4 Patient Controlled Analgesics (PCA)
4.5.2.5 Volumetric Pumps Market
4.5.2. Intravenous Sets
4.5.3. IV cannulas
4.5.4. Needleless connectors

Chapter 5. Home Infusion Therapy Market: Segment Analysis, By Application, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Home Infusion Therapy Market, By Application, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Anti-Infective
5.5.2. Endocrinology
5.5.2.1 Diabetes
5.5.2.2 Others
5.5.3. Hydration Therapy
5.5.3.1. Athletes
5.5.3.2. Others
5.5.4. Chemotherapy
5.5.5. Enteral Nutrition
5.5.6. Parenteral Nutrition
5.5.7. Specialty Pharmaceuticals
5.5.8. Others

Chapter 6. Home Infusion Therapy Market: Regional Market Analysis, by Product, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.13. Sweden
6.8.13.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.8.13.2 Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.9.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.3. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.10. Indonesia
6.9.10.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.10.2. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.10 Singapore
6.9.10.3. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.10.4. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.11 Philippines
6.9.10.5. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.10.6. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.9.12 Thailand
6.9.10.7. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.9.10.8. Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10 Latin America
6.10.1 Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.10.2 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.3 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10.4 Brazil
6.10.4.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.4.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10.5 Mexico
6.10.5.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.5.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10.6 Argentina
6.10.6.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.6.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10.7 Colombia
6.10.7.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.7.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.10.8 Chile
6.10.8.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.10.8.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11 Middle East and Africa
6.11.1 Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.11.2 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.3 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11.4 South Africa
6.11.4.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.4.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11.5 Saudi Arabia
6.11.5.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.5.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11.6 UAE
6.11.6.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.6.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11.7 Israel
6.11.7.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.7.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)
6.11.8 Egypt
6.11.8.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
6.11.8.2 Market estimates and forecast, by Application , 2016 - 2027 (USD Million)

Chapter 7 Home Infusion Therapy Market - Competitive Analysis
7.1 Key companies profiled
7.1.1 Caesarea Medical Electronics
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 CareFusion Corporation
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Baxter
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 B. Braun Melsungen AG
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Fresenius Kabi
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 ICU Medical, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 JMS Co. Ltd.
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Smiths Medical
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic Initiatives
7.1.9 Terumo Corporation
7.1.9.1 Company Overview
7.1.9.2 Financial Performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic Initiatives

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Baxter
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • Smiths Medical
  • Terumo Corporation
Note: Product cover images may vary from those shown
Adroll
adroll